Dow AgroSciences Monsanto Licenses Dow AgroSciences Gene-Editing Tech for Agricultural Use The technology is based on engineered zinc finger DNA-binding proteins, which bind to specific functional domains to create transcription factors capable of activating or repressing target genes. Genome Canada Announces Funding for Industry, Academic Research Partnerships The funding will support support two alliances between industry and academia that are applying genomic technologies to agriculture and healthcare. Dow AgroSciences, Radiant Genomics Expand R&D Collaboration The deal expands the companies' ongoing collaboration, which began in mid-2015, to include additional natural product targets in crop protection and traits. Dow AgroSciences, Critical Path Services Reach License Agreement Critical Path will license Dow AgroScience's Plextein technology for multiplex detection of plant proteins using mass spectroscopy and provide it as a service. Dow AgroSciences Inks Deal for Rice Genome-Editing Technology in China The company will work with the Institute of Crop Sciences of the Chinese Academy of Agricultural Sciences to develop the technology into a rice genome-editing platform. May 29, 2015 Dow AgroSciences Publishes New Data on Use of RNAi Against Corn Pest Premium Apr 2, 2015 Dow AgroSciences, Radiant Genomics Form R&D Collaboration Jul 31, 2014 Genomics in the Journals: Arrays 2014.07.31 May 22, 2014 Sigma-Aldrich to Supply ZFN Reagents for Dow AgroSciences Sep 6, 2013 String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms Premium Jul 9, 2013 Evotec, Dow AgroSciences Enter Proteomics Service Deal Apr 25, 2013 Through Licensing Deal, Dow AgroSciences Gains Access to Monsanto RNAi Tech Premium Aug 31, 2012 Dow Partners with Victoria's Ag Research Department Aug 17, 2012 In Brief This Week: Myriad Genetics; Sequenta; Dow AgroSciences; EA, Illumina, Golden Helix Jul 18, 2011 Dow AgroSciences Grants License to Danforth Center to Improve Cassava Crop May 2, 2011 Dow, Oregon State University Partner on Gene Modification Aug 6, 2010 Dow AgroSciences, Syngenta Sign on as First Corporate Sponsors for TAIR Premium Jan 15, 2010 In Brief This Week: Response Genetics, Dow AgroSciences, Monsanto, Stokes Bio, Cellectis, Sage Bionetworks, HairDx Nov 13, 2009 In Brief This Week: Dow AgroSciences; Chromatin; OriGene Technologies; Jubliant Biosys; Pacific Biosciences; CamStar Systems Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.